Liyuan Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liyuan Han has a total of 358 co-authors. Here are the top co-authors by number of shared publications:
Ruijie Zhang
Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo No. 2 Hospital, Ningbo, China
13 shared publicationsTian Zhao
Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry
13 shared publicationsLiyuan Pu
Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Wenzhou Medical University, 315000 Ningbo, Zhejiang, China; Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Guoke Ningbo Life Science and Health Industry Research Institute, University of Chinese Academy of Sciences, 315000 Ningbo, Zhejiang, China
12 shared publicationsGuodong Xu
Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, PR China
7 shared publications- Li Ping Wong
Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China
7 shared publications - Ruijie Zhang
School of Public Health, Southeast University, Nanjing, China
7 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Springer Nature in BMC Bioinformatics
- Vol. 27 (1)
Multi-task deep learning for risk stratification and shared molecular architecture of cardiometabolic multimorbidity under fragmented multi-omics
Cardiometabolic multimorbidity (CMM) reflects a systemic failure of interconnected physiological networks, yet current risk stratification approaches based on macroscopic clinical phenotypes leave substantial molecular residual risk unresolved. Although multi-omics integration offers a means to capture this latent vulnerability, its population-scale application is limited by pervasive fragmentation and non-overlapping availability of proteomic and metabolomic data. Here, we develop the Multi-Omics Perceiver for Survival (MOP-Surv), a deep learning framework designed to accommodate incomplete multi-omics profiles without imputation through dynamic attention masking and multi-task survival learning. Applied to 297,067 UK Biobank participants, MOP-Surv achieved consistent risk stratification across six cardiometabolic endpoints and provided modest incremental predictive value. Beyond prediction, MOP-Surv identified a hierarchical structure of cross-endpoint prognostic associations and highlighted a parsimonious set of biomarkers including GDF15, EDA2R, and WFDC2 with consistent prognostic relevance across diverse disease trajectories. Therefore MOP-Surv provides a practical approach for integrating fragmented multi-omics data to characterize shared prognostic patterns across cardiometabolic outcomes.
- 24 August 2026
- Published by Springer Nature in BMC Bioinformatics
- Vol. 27 (1)
Open AccessMulti-task deep learning for risk stratification and shared molecular architecture of cardiometabolic multimorbidity under fragmented multi-omics
Cardiometabolic multimorbidity (CMM) reflects a systemic failure of interconnected physiological networks, yet current risk stratification approaches based on macroscopic clinical phenotypes leave substantial molecular residual risk unresolved. Although multi-omics integration offers a means to capture this latent vulnerability, its population-scale application is limited by pervasive fragmentation and non-overlapping availability of proteomic and metabolomic data. Here, we develop the Multi-Omics Perceiver for Survival (MOP-Surv), a deep learning framework designed to accommodate incomplete multi-omics profiles without imputation through dynamic attention masking and multi-task survival learning. Applied to 297,067 UK Biobank participants, MOP-Surv achieved consistent risk stratification across six cardiometabolic endpoints and provided modest incremental predictive value. Beyond prediction, MOP-Surv identified a hierarchical structure of cross-endpoint prognostic associations and highlighted a parsimonious set of biomarkers including GDF15, EDA2R, and WFDC2 with consistent prognostic relevance across diverse disease trajectories. Therefore MOP-Surv provides a practical approach for integrating fragmented multi-omics data to characterize shared prognostic patterns across cardiometabolic outcomes.
- 27 July 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (9) , 4823-4830
Identification of Immune Response-Related Proteomic Biomarkers in Moyamoya Disease Using Serum Olink Proteomics
Moyamoya disease, a rare chronic cerebrovascular disorder, requires invasive digital subtraction angiography (DSA) for diagnosis. This study employed high-throughput proteomics to identify plasma biomarkers for Moyamoya disease diagnosis. We conducted immunopanel analysis using the Olink platform to evaluate 92 immune-related proteins in plasma samples from 88 Moyamoya disease patients and 88 healthy controls. Key proteins were identified through differential expression analysis, GO, and KEGG enrichment analysis. A diagnostic model was constructed using LASSO regression, Boruta algorithm, and machine learning models including random forest and XGBoost. Validation of these proteins was performed using GEO external data sets, followed by prediction of potential therapeutic drugs and molecular docking validation through pharmacogenomic databases. A total of 44 differentially expressed proteins were identified through the Olink immunopanel, with 12 downregulated and 32 upregulated. GO and KEGG analyses revealed significant enrichment of these proteins in innate immune responses and signaling pathways such as NF-kB and MAPK. Through LASSO, random forest, and protein under-area analysis, four potential biomarkers for Moyamoya disease (MGMT, SIT1, PRDX1, TRAF2) were identified. A diagnostic model using these proteins showed the highest AUC value with the XGBoost model. Additionally, TRAF2 and PRDX1 exhibited significant expression differences in Moyamoya disease patients within the GEO data set. Our study revealed the immune landscape of Moyamoya disease, identified four biomarkers, and established a variety of diagnostic models.
- 27 July 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (9) , 4823-4830
Identification of Immune Response-Related Proteomic Biomarkers in Moyamoya Disease Using Serum Olink Proteomics
Moyamoya disease, a rare chronic cerebrovascular disorder, requires invasive digital subtraction angiography (DSA) for diagnosis. This study employed high-throughput proteomics to identify plasma biomarkers for Moyamoya disease diagnosis. We conducted immunopanel analysis using the Olink platform to evaluate 92 immune-related proteins in plasma samples from 88 Moyamoya disease patients and 88 healthy controls. Key proteins were identified through differential expression analysis, GO, and KEGG enrichment analysis. A diagnostic model was constructed using LASSO regression, Boruta algorithm, and machine learning models including random forest and XGBoost. Validation of these proteins was performed using GEO external data sets, followed by prediction of potential therapeutic drugs and molecular docking validation through pharmacogenomic databases. A total of 44 differentially expressed proteins were identified through the Olink immunopanel, with 12 downregulated and 32 upregulated. GO and KEGG analyses revealed significant enrichment of these proteins in innate immune responses and signaling pathways such as NF-kB and MAPK. Through LASSO, random forest, and protein under-area analysis, four potential biomarkers for Moyamoya disease (MGMT, SIT1, PRDX1, TRAF2) were identified. A diagnostic model using these proteins showed the highest AUC value with the XGBoost model. Additionally, TRAF2 and PRDX1 exhibited significant expression differences in Moyamoya disease patients within the GEO data set. Our study revealed the immune landscape of Moyamoya disease, identified four biomarkers, and established a variety of diagnostic models.
- 20 May 2026
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 147, 111751
Integrating multi-omics analysis to identify potential biomarkers and regulatory networks of ischemic stroke
- 20 May 2026
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 147, 111751
Integrating multi-omics analysis to identify potential biomarkers and regulatory networks of ischemic stroke
- 24 March 2026
- Published by Springer Nature in Translational Stroke Research
- Vol. 17 (2) , 34
Plasma Metabolic Signature and Single-Cell Regulatory Network for Ischemic Stroke
- 24 March 2026
- Published by Springer Nature in Translational Stroke Research
- Vol. 17 (2) , 34
Plasma Metabolic Signature and Single-Cell Regulatory Network for Ischemic Stroke
- 1 December 2025
- Published by Springer Nature in Metabolomics
- Vol. 22 (1) , 2
Non-targeted metabolomics can identify disease-specific characteristics of ischemic stroke
Introduction Ischemic stroke (IS) is a leading cause of disability and mortality. Metabolomics, in conjunction with machine learning (ML), can be employed to identify potential biomarkers associated with this condition. Objective We aimed to utilize metabolomics to evaluated the potential biomarkers and crucial metabolic pathways linked with IS. Furthermore, to construct a predictive model employing ML algorithms. Methods We conducted non-targeted liquid chromatography-tandem mass spectrometry-based plasma analysis on 786 study participants (discovery set IS/control group = 198/198; external validation set IS patients/control group = 195/195). The aim was to identify differential metabolites and examine metabolic pathways potentially related to the etiology of IS using pathway enrichment analysis. Feature variables were screened using the Least Absolute Shrinkage and Selection Operator and random forest algorithm. We employed XGBoost to construct prediction models for these feature variables, and utilized various evaluation indicators to assess model performance. This was subsequently confirmed in an independent external validation set. Results In the comparison between the IS group and the control group, 200 differential metabolites were detected. Notable dysbiotic pathways encompass arachidonic acid metabolism and folate biosynthesis among others. Four significant metabolites were further investigated to differentiate between the IS group and the control group: Calcitroic acid, Diguanosine tetraphosphate, PC (P-18:0/P-18:1(9Z)), and Deoxycholic acid. The XGBoost model exhibited an AUC of 1.000 for the training set and 0.992 for the test set in the discovery columns, while the external independent validation set recorded an AUC of 0.941. Conclusion Our study unveiled the metabolic landscape of IS, identified four biomarkers, and developed a prediction model that effectively differentiates between the IS group and the control group based on these four biomarkers. Graphical abstract Research Flowchart; Subfigure A delineates the information pertaining to the clinical cohorts and conducts a preliminary metabolomics analysis, whereas Subfigure B elucidates the application of machine learning to metabolomics.
- 1 December 2025
- Published by Springer Nature in Metabolomics
- Vol. 22 (1) , 2
Non-targeted metabolomics can identify disease-specific characteristics of ischemic stroke
Introduction Ischemic stroke (IS) is a leading cause of disability and mortality. Metabolomics, in conjunction with machine learning (ML), can be employed to identify potential biomarkers associated with this condition. Objective We aimed to utilize metabolomics to evaluated the potential biomarkers and crucial metabolic pathways linked with IS. Furthermore, to construct a predictive model employing ML algorithms. Methods We conducted non-targeted liquid chromatography-tandem mass spectrometry-based plasma analysis on 786 study participants (discovery set IS/control group = 198/198; external validation set IS patients/control group = 195/195). The aim was to identify differential metabolites and examine metabolic pathways potentially related to the etiology of IS using pathway enrichment analysis. Feature variables were screened using the Least Absolute Shrinkage and Selection Operator and random forest algorithm. We employed XGBoost to construct prediction models for these feature variables, and utilized various evaluation indicators to assess model performance. This was subsequently confirmed in an independent external validation set. Results In the comparison between the IS group and the control group, 200 differential metabolites were detected. Notable dysbiotic pathways encompass arachidonic acid metabolism and folate biosynthesis among others. Four significant metabolites were further investigated to differentiate between the IS group and the control group: Calcitroic acid, Diguanosine tetraphosphate, PC (P-18:0/P-18:1(9Z)), and Deoxycholic acid. The XGBoost model exhibited an AUC of 1.000 for the training set and 0.992 for the test set in the discovery columns, while the external independent validation set recorded an AUC of 0.941. Conclusion Our study unveiled the metabolic landscape of IS, identified four biomarkers, and developed a prediction model that effectively differentiates between the IS group and the control group based on these four biomarkers. Graphical abstract Research Flowchart; Subfigure A delineates the information pertaining to the clinical cohorts and conducts a preliminary metabolomics analysis, whereas Subfigure B elucidates the application of machine learning to metabolomics.
- 3 January 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 974
Correction to “Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression”
- 3 January 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 974
Correction to “Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression”
- Open Access
- 16 December 2024
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (6) , 1985-1992
Mendelian randomization analysis of the causal relationship between trimethylamine N oxide and its precursors and Parkinson’s disease
Introduction: Previous studies have reported a potential association between trimethylamine N-oxide (TMAO) and Parkinson’s disease (PD). The objective of this study was to examine the potential relationship between the levels of circulating TMAO and its precursors and the risk of PD using a two-sample Mendelian randomization (MR) approach.Material and methods: We aggregated data from three genome-wide association studies (International Parkinson’s Disease Genomics Consortium, Parkinson’s Research: The Organized Genetics Initiative and GenePD, and FinnGen) to extract single-nucleotide polymorphisms (SNPs) associated with circulating concentrations of TMAO, choline, carnitine, and betaine. These SNPs were employed as instrumental variables in a random-effects model to evaluate the causal relationship between circulating concentrations of TMAO and its precursors and the risk of Parkinson’s disease, by estimating odds ratios with accompanying 95% confidence intervals. The primary analysis employed the inverse variance-weighted (IVW) method, which was complemented with MR-Egger regression analysis.Results: The analysis using the IVW method, which aggregated data from the three databases, did not show any causal relationship between circulating concentrations of TMAO and its precursors, and the risk of PD (p > 0.05). This finding was further confirmed by the results of the MR-Egger analysis. A sensitivity analysis demonstrated that the results were not influenced by any biases, and a heterogeneity test indicated no significant variation among the SNPs.Conclusions: This study did not identify any conclusive evidence of a causal association between the circulating concentrations of TMAO or its precursors and the risk of PD. Further investigation is warranted to determine whether such an association indeed exists.
- 16 December 2024
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (6) , 1985-1992
Open AccessMendelian randomization analysis of the causal relationship between trimethylamine N oxide and its precursors and Parkinson’s disease
Introduction: Previous studies have reported a potential association between trimethylamine N-oxide (TMAO) and Parkinson’s disease (PD). The objective of this study was to examine the potential relationship between the levels of circulating TMAO and its precursors and the risk of PD using a two-sample Mendelian randomization (MR) approach.Material and methods: We aggregated data from three genome-wide association studies (International Parkinson’s Disease Genomics Consortium, Parkinson’s Research: The Organized Genetics Initiative and GenePD, and FinnGen) to extract single-nucleotide polymorphisms (SNPs) associated with circulating concentrations of TMAO, choline, carnitine, and betaine. These SNPs were employed as instrumental variables in a random-effects model to evaluate the causal relationship between circulating concentrations of TMAO and its precursors and the risk of Parkinson’s disease, by estimating odds ratios with accompanying 95% confidence intervals. The primary analysis employed the inverse variance-weighted (IVW) method, which was complemented with MR-Egger regression analysis.Results: The analysis using the IVW method, which aggregated data from the three databases, did not show any causal relationship between circulating concentrations of TMAO and its precursors, and the risk of PD (p > 0.05). This finding was further confirmed by the results of the MR-Egger analysis. A sensitivity analysis demonstrated that the results were not influenced by any biases, and a heterogeneity test indicated no significant variation among the SNPs.Conclusions: This study did not identify any conclusive evidence of a causal association between the circulating concentrations of TMAO or its precursors and the risk of PD. Further investigation is warranted to determine whether such an association indeed exists.
- Open Access
Association between a healthy lifestyle and the prevalence of depression in radiology residents in China: findings from a nationwide survey
Objective The relationship between a healthy lifestyle and depression in radiology residents remains poorly understood. This study aims to investigate the relationship between a healthy lifestyle and depressive symptoms in radiology residents in a nationwide survey. Design Cross-sectional study. Setting The survey was conducted among radiology residents undergoing training in China between December 2020 and April 2021. This encompassed a total of 215 municipalities and 406 training centres. Participants 3677 radiology residents in 31 provinces of China. Primary and secondary outcome measures The primary outcome was Healthy Lifestyle Score (HLS). A multiple logistic regression analysis was performed to evaluate the association between lifestyle factors and depressive symptoms. Additionally, the weighted quantile sum (WQS) index was utilised to identify the lifestyle factor that had the greatest impact on depressive symptoms. Results The study sample consisted of 3677 participants, among whom the prevalence of depression was 34.7%. Participants were categorised based on their Health Lifestyle Score (HLS) into three groups: low HLS (LHLS), moderate HLS (MHLS) and high HLS (HHLS), with proportions of 8.0%, 79.8% and 12.2%, respectively. Those with LHLS were found to have a significantly higher risk of depression (OR: 5.21, 95% CI: 3.72 to 7.30) and a more severe level of depression (p for trendConclusion The study establishes a significant association between an LHLS (long and irregular work hours) and an elevated risk of depressive symptoms among the participants, emphasising the crucial role of sleep in this relationship. These findings underline the importance of promoting a healthy lifestyle, specifically emphasising the need for adequate sleep, among radiology residents.
Open AccessAssociation between a healthy lifestyle and the prevalence of depression in radiology residents in China: findings from a nationwide survey
Objective The relationship between a healthy lifestyle and depression in radiology residents remains poorly understood. This study aims to investigate the relationship between a healthy lifestyle and depressive symptoms in radiology residents in a nationwide survey. Design Cross-sectional study. Setting The survey was conducted among radiology residents undergoing training in China between December 2020 and April 2021. This encompassed a total of 215 municipalities and 406 training centres. Participants 3677 radiology residents in 31 provinces of China. Primary and secondary outcome measures The primary outcome was Healthy Lifestyle Score (HLS). A multiple logistic regression analysis was performed to evaluate the association between lifestyle factors and depressive symptoms. Additionally, the weighted quantile sum (WQS) index was utilised to identify the lifestyle factor that had the greatest impact on depressive symptoms. Results The study sample consisted of 3677 participants, among whom the prevalence of depression was 34.7%. Participants were categorised based on their Health Lifestyle Score (HLS) into three groups: low HLS (LHLS), moderate HLS (MHLS) and high HLS (HHLS), with proportions of 8.0%, 79.8% and 12.2%, respectively. Those with LHLS were found to have a significantly higher risk of depression (OR: 5.21, 95% CI: 3.72 to 7.30) and a more severe level of depression (p for trendConclusion The study establishes a significant association between an LHLS (long and irregular work hours) and an elevated risk of depressive symptoms among the participants, emphasising the crucial role of sleep in this relationship. These findings underline the importance of promoting a healthy lifestyle, specifically emphasising the need for adequate sleep, among radiology residents.
- 28 October 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 23 (12) , 5421-5437
Multiomics Profiling of Plasma Reveals Molecular Alterations Prior to a Diagnosis with Stroke Among Chinese Hypertension Patients
We aimed to investigate the correlation between plasma proteins and metabolites and the occurrence of future strokes using mass spectrometry and bioinformatics as well as to identify other biomarkers that could predict stroke risk in hypertensive patients. In a nested case-control study, baseline plasma samples were collected from 50 hypertensive subjects who developed stroke and 50 gender-, age- and body mass index-matched controls. Plasma untargeted metabolomics and data independent acquisition-based proteomics analysis were performed in hypertensive patients, and 19 metabolites and 111 proteins were found to be differentially expressed. Integrative analyses revealed that molecular changes in plasma indicated dysregulation of protein digestion and absorption, salivary secretion, and regulation of actin cytoskeleton, along with significant metabolic suppression. C4BPA, Caprolactam, Col15A1, and HBB were identified as predictors of stroke occurrence, and the Support Vector Machines (SVM) model was determined to be the optimal predictive model by integrating six machine-learning classification models. The SVM model showed strong performance in both the internal validation set (area under the curve [AUC]: 0.977, 95% confidence interval [CI]: 0.941-1.000) and the external independent validation set (AUC: 0.973, 95% CI: 0.921-0.999).
- 28 October 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 23 (12) , 5421-5437
Multiomics Profiling of Plasma Reveals Molecular Alterations Prior to a Diagnosis with Stroke Among Chinese Hypertension Patients
We aimed to investigate the correlation between plasma proteins and metabolites and the occurrence of future strokes using mass spectrometry and bioinformatics as well as to identify other biomarkers that could predict stroke risk in hypertensive patients. In a nested case-control study, baseline plasma samples were collected from 50 hypertensive subjects who developed stroke and 50 gender-, age- and body mass index-matched controls. Plasma untargeted metabolomics and data independent acquisition-based proteomics analysis were performed in hypertensive patients, and 19 metabolites and 111 proteins were found to be differentially expressed. Integrative analyses revealed that molecular changes in plasma indicated dysregulation of protein digestion and absorption, salivary secretion, and regulation of actin cytoskeleton, along with significant metabolic suppression. C4BPA, Caprolactam, Col15A1, and HBB were identified as predictors of stroke occurrence, and the Support Vector Machines (SVM) model was determined to be the optimal predictive model by integrating six machine-learning classification models. The SVM model showed strong performance in both the internal validation set (area under the curve [AUC]: 0.977, 95% confidence interval [CI]: 0.941-1.000) and the external independent validation set (AUC: 0.973, 95% CI: 0.921-0.999).
- Open Access
- 28 October 2024
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (5) , 1472-1483
Income level is associated with differences in primary and secondary stroke prevention in China
Introduction: The aim of this study was to assess differences in the effects of income level on the primary and secondary prevention of stroke in the Chinese population.Material and methods: This was a population-based study using data from a China Kadoorie Biobank survey that began in 2004 in 10 geographical regions. Community residents (n = 512,715) aged 30–79 years were recruited. Stroke was determined by the self-reporting of a doctor’s diagnosis, and participants with a high risk of stroke were identified using the model developed in the Prediction for ASCVD Risk in China study.Results: The final numbers of people included in this study were 8,884 with stroke and 218,972 with a high risk of stroke. The participants’ income level was positively associated with high levels of physical activity and the consumption of a healthy diet, but negatively associated with the control of alcohol consumption (all p < 0.05). In addition, positive associations were observed between the control of smoking and the use of antiplatelet and antihypertensive medication for primary prevention (all p < 0.05), but there was a negative association with the control of blood pressure (p < 0.001).Conclusions: Low-income individuals were less likely to control smoking and their diet and use preventive medications, while high-income individuals were less likely to control their alcohol consumption and blood pressure. Moreover, medication use was low for both primary and secondary prevention in high-income individuals.
- 28 October 2024
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (5) , 1472-1483
Open AccessIncome level is associated with differences in primary and secondary stroke prevention in China
Introduction: The aim of this study was to assess differences in the effects of income level on the primary and secondary prevention of stroke in the Chinese population.Material and methods: This was a population-based study using data from a China Kadoorie Biobank survey that began in 2004 in 10 geographical regions. Community residents (n = 512,715) aged 30–79 years were recruited. Stroke was determined by the self-reporting of a doctor’s diagnosis, and participants with a high risk of stroke were identified using the model developed in the Prediction for ASCVD Risk in China study.Results: The final numbers of people included in this study were 8,884 with stroke and 218,972 with a high risk of stroke. The participants’ income level was positively associated with high levels of physical activity and the consumption of a healthy diet, but negatively associated with the control of alcohol consumption (all p < 0.05). In addition, positive associations were observed between the control of smoking and the use of antiplatelet and antihypertensive medication for primary prevention (all p < 0.05), but there was a negative association with the control of blood pressure (p < 0.001).Conclusions: Low-income individuals were less likely to control smoking and their diet and use preventive medications, while high-income individuals were less likely to control their alcohol consumption and blood pressure. Moreover, medication use was low for both primary and secondary prevention in high-income individuals.